C WorldWide Group’s Aerie Pharmaceuticals AERI Stock Holding History

C WorldWide Group’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,156,142	Closed	-$8.67M	–	92
2022 Q2	$8.67M	Hold	1,156,142	–	–	0.11%	48
2022 Q1	$10.5M	Hold	1,156,142	–	–	0.11%	47
2021 Q4	$8.12M	Hold	1,156,142	–	–	0.08%	54
2021 Q3	$13.2M	Hold	1,156,142	–	–	0.14%	40
2021 Q2	$18.5M	Hold	1,156,142	–	–	0.19%	39
2021 Q1	$20.7M	Sell	1,156,142 -300,000	-21%	-$5.18M	0.2%	39
2020 Q4	$19.7M	Hold	1,456,142	–	–	0.2%	42
2020 Q3	$17.1M	Buy	1,456,142 +900,000	+162%	+$11M	0.19%	42
2020 Q2	$8.21M	Hold	556,142	–	–	0.1%	53
2020 Q1	$7.51M	Hold	556,142	–	–	0.1%	48
2019 Q4	$13.4M	Hold	556,142	–	–	0.16%	43
2019 Q3	$10.7M	Buy	556,142 +100,000	+22%	+$2.29M	0.14%	46
2019 Q2	$13.5M	Buy	456,142 +320,000	+235%	+$12.3M	0.17%	43
2019 Q1	$6.47M	Buy	136,142 +55,127	+68%	+$2.43M	0.08%	47
2018 Q4	$2.92M	Sell	81,015 -27,251	-25%	-$1.28M	0.04%	63
2018 Q3	$6.66M	Sell	108,266 -2,572	-2%	-$165K	0.09%	56
2018 Q2	$7.49M	Buy	110,838 +38,099	+52%	+$2.13M	0.1%	50
2018 Q1	$3.95M	Sell	72,739 -9,449	-11%	-$528K	0.06%	60
2017 Q4	$4.91M	Sell	82,188 -7,196	-8%	-$436K	0.07%	59
2017 Q3	$4.34M	Sell	89,384 -165	-0.2%	-$9K	0.06%	69
2017 Q2	$4.71M	Buy	89,549 +13,458	+18%	+$627K	0.07%	64
2017 Q1	$3.45M	Buy	76,091 +4,008	+6%	+$179K	0.06%	69
2016 Q4	$2.73M	Sell	72,083 -69,417	-49%	-$2.63M	0.05%	70
2016 Q3	$5.34M	Sell	141,500 -50,506	-26%	-$1.11M	0.09%	51
2016 Q2	$3.38M	Hold	192,006	–	–	0.06%	56
2016 Q1	$2.33M	Hold	192,006	–	–	0.05%	65
2015 Q4	$4.67M	Sell	192,006 -9,344	-5%	-$218K	0.08%	55
2015 Q3	$3.57M	Sell	201,350 -125,153	-38%	-$2.27M	0.06%	67
2015 Q2	$5.76M	Buy	326,503 +235,600	+259%	+$4.32M	0.08%	54
2015 Q1	$2.85M	Hold	90,903	–	–	0.04%	73
2014 Q4	$2.65M	Sell	90,903 -39,097	-30%	-$991K	0.04%	67
2014 Q3	$2.69M	Buy	+130,000	New	+$2.56M	0.04%	71

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

C WorldWide Group's AERI Position: Q3 2022 in Review

C WorldWide Group sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 1,156,142 shares — an estimated $8.67M sold.

C WorldWide Group first reported a position in AERI in Q3 2014 and held it in 32 quarters. The position peaked at $20.7M in Q1 2021. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

C WorldWide Group reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
C WorldWide Group sold 1,156,142 Aerie Pharmaceuticals shares in Q3 2022, an estimated $8.67M.
C WorldWide Group first reported a position in Aerie Pharmaceuticals in Q3 2014 and held it in 32 quarters.
C WorldWide Group's Aerie Pharmaceuticals position peaked at $20.7M in Q1 2021.
156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on C WorldWide Group's 13F filing for Q3 2022, filed 3 Nov 2022.